A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine
Immunogenicity And Safety Of An Alum-Adjuvanted Inactivated H7N9 Influenza Vaccine
Sponsor: Henan Center for Disease Control and Prevention
A PHASE1/PHASE2 clinical study on H7N9 Influenza, this trial is completed. The trial is conducted by Henan Center for Disease Control and Prevention and has accumulated 10 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Nov 2024 — Present [monthly]
Completed PHASE1/PHASE2
Status: Unknown → Completed
-
Sep 2024 — Nov 2024 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
May 2020 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
Status: Active Not Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Apr 2019 — May 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — May 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Henan Center for Disease Control and Prevention
- Shanghai Institute Of Biological Products
For direct contact, visit the study record on ClinicalTrials.gov .